Literature DB >> 28799919

Virological outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in antiretroviral-naive HIV-1-infected participants with baseline HIV-1 RNA ≥1,000,000 copies/ml: a post hoc analysis of Phase III clinical trials.

Paul Sax1, Edwin DeJesus2, David Wohl3, Jennifer DeMorin4, Damian McColl4, David Piontkowsky4, Calvin Cohen4, Hui Wang5, Kirsten White6, Christian Callebaut6, Martin Rhee7, Moupali Das7, Erin Quirk7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28799919     DOI: 10.3851/IMP3187

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


× No keyword cloud information.
  1 in total

1.  Is the Treatment Response Different in Treatment-naive HIV-infected Patients with Very High Viral Load (>1 Million Copies)? Three-year Data

Authors:  Özlem Kandemir; Elif Şahin Horosan; Serhat Şahinoğlu
Journal:  Balkan Med J       Date:  2020-03-25       Impact factor: 2.021

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.